DePaul Blue Demons take on the Grambling Tigers on 3-game skid
Published Nov. 20, 2025 4:42 a.m. ET
Associated Press
Grambling Tigers (1-4) at DePaul Blue Demons (1-3)
Chicago; Friday, 6:30 p.m. EST
BOTTOM LINE: DePaul enters the matchup with Grambling as losers of three in a row.
DePaul went 13-19 overall last season while going 8-8 at home. The Blue Demons averaged 65.2 points per game while allowing opponents to score 70.4 last season.
The Tigers are 0-4 on the road. Grambling leads the SWAC with 15.0 offensive rebounds per game led by Shaniah Nunn averaging 3.8.
___
The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.
share
recommended
College Basketball 2025-2026 Buzz: Saint Louis Extends Coach Josh Schertz
Last Night in College Basketball: Gonzaga Men and Women Win West Coast Titles
2026 NCAA Women's Basketball Tournament Automatic Bids Tracker
Women's College Basketball Top 10, Bubble Team NET Rankings: UCLA, UConn Dominate
2025-26 Women's March Madness Odds: Texas Surges After Winning SEC Title
Last Night in College Basketball: UConn Makes its March Madness Bid Official
Top 10 Women's College Basketball Players with the Highest NIL Valuations
Who are the 10 best players in UConn women's basketball history?
Item 1 of 3
in this topic
recommended
College Basketball 2025-2026 Buzz: Saint Louis Extends Coach Josh Schertz
Last Night in College Basketball: Gonzaga Men and Women Win West Coast Titles
2026 NCAA Women's Basketball Tournament Automatic Bids Tracker
Women's College Basketball Top 10, Bubble Team NET Rankings: UCLA, UConn Dominate
2025-26 Women's March Madness Odds: Texas Surges After Winning SEC Title
Last Night in College Basketball: UConn Makes its March Madness Bid Official
Top 10 Women's College Basketball Players with the Highest NIL Valuations
Who are the 10 best players in UConn women's basketball history?
Item 1 of 3
FOX SPORTS™, SPEED™, SPEED.COM™ & © 2026 Fox Media LLC
and Fox Sports Interactive Media, LLC. All rights reserved. Use of this
website (including any and all parts and components) constitutes your
acceptance of these
Terms of Use and New Privacy Policy | Advertising Choices | Your Privacy Choices | Closed Captioning
